New Study Confirms CoQ10’s Benefit On Kidney Disease

New research has concluded chronic kidney disease patients can benefit from supplementation with the antioxidant coenzyme Q10 (CoQ10). Chronic kidney disease is a condition where the kidney’s, the body’s blood filters function at reduced capacity or no longer function at all. The kidneys normally filter out the waste of the blood flowing through them, allowing the body to release the waste through urine.

With chronic kidney disease, the waste materiel does not get filtered out and begins to build in the blood stream. Fatigue and organ damage can occur, in addition to all-cause mortality, diabetic nephropathy, cardiovascular events and hospitalization. The risks to cardiovascular disease with chronic kidney disease are present regardless of existing risk factors and a history of Cardiovascular Disease.

Research was conducted at Shiraz University of Medical Sciences. Seven randomized controlled trials including 384 men and woman were looked at. Researchers looked at riglycerides, total cholesterol, low density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, glucose, insulin, insulin resistance, C-reactive protein, malondialdehyde and creatinine.

Malondialdehyde is a sign of oxidative stress in the human body. Creatinine levels are elevated when a person contracts chronic kidney disease. Dosage of CoQ10 ranged from 30 milligrams to 200 milligrams administered over periods of 4 to 12 weeks.

For the very first in all natural kidney health research and studies, be sure to follow us on Twitter.